Anavex Life Sciences

Anavex Life Sciences

AVXL· Manufacturing· Fiscal year ends in September

CEO pay in FY2024Stock -13.3% in FY2024

Christopher Missling is the CEO of Anavex Life Sciences and was paid $2.8M in FY2024 (Sep), down 29%.

Pay$100 in the stock at the end of FY20 → $125
CEO pay is from each Anavex Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives2

See all
  1. 1Christopher MisslingFY2024
  2. 2Sandra BoenischFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Anavex Life Sciences paid its 2 named executives $3.2M in total in FY2024 (Sep). CEO Christopher Missling was paid $2.8M of that.

Name
Christopher MisslingPresident, Chief Executive Officer and Director
Sandra BoenischNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Anavex Life Sciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings5

See all
Annual report10-KNov 25, 2025FY2025
Proxy statementDEF 14AApr 25, 2025FY2024
Annual report10-KDec 23, 2024FY2024
Proxy statementDEF 14AMay 6, 2024FY2023
Annual report10-KNov 27, 2023FY2023
For the press:Download CSVDownload PNGHow to use our data